Armata Pharmaceuticals - ARMP Stock Forecast, Price & News

Armata Pharmaceuticals' stock was trading at $4.87 at the start of the year. Since then, ARMP stock has decreased by 13.2% and is now trading at $4.2250.
View the best growth stocks for 2022 here.

Armata Pharmaceuticals saw a decrease in short interest in June. As of June 30th, there was short interest totaling 73,600 shares, a decrease of 20.6% from the June 15th total of 92,700 shares. Based on an average daily volume of 6,100 shares, the days-to-cover ratio is currently 12.1 days. Currently, 0.7% of the shares of the stock are short sold.
View Armata Pharmaceuticals' Short Interest.

Armata Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Wednesday, August 10th 2022.
View our ARMP earnings forecast.

Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP) released its quarterly earnings results on Thursday, May, 12th. The company reported ($0.30) EPS for the quarter, missing the consensus estimate of ($0.20) by $0.10. The company earned $1.24 million during the quarter, compared to analyst estimates of $0.95 million. Armata Pharmaceuticals had a negative trailing twelve-month return on equity of 75.90% and a negative net margin of 569.21%.

Based on aggregate information from My MarketBeat watchlists, some companies that other Armata Pharmaceuticals investors own include VBI Vaccines (VBIV), Vaxart (VXRT), Amarin (AMRN), CRISPR Therapeutics (CRSP), Pfizer (PFE), Micron Technology (MU), Aduro Biotech (ADRO), Occidental Petroleum (OXY) and Gilead Sciences (GILD).

Armata Pharmaceuticals trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ARMP."

Shares of ARMP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ARMP stock can currently be purchased for approximately $4.23.

Armata Pharmaceuticals (NYSEAMERICAN:ARMP) has a market capitalization of $152.57 million and generates $4.47 million in revenue each year. The company earns $-23,160,000.00 in net income (profit) each year or ($1.00) on an earnings per share basis.

Armata Pharmaceuticals employs 69 workers across the globe.

Armata Pharmaceuticals' mailing address is 4503 GLENCOE AVENUE, MARINA DEL REY CA, 90292. The official website for the company is www.armatapharma.com. The company can be reached via phone at (310) 655-2928, via email at jallaire@lifesciadvisors.com, or via fax at 310-665-2963.